NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

I should have used the word "affected".

I don't think this will hold up UCLA/NW Bio negotiations with big Pharma (BO). These patents methods are already approved in the US. If they branch out to test internationally, then yes.

On that note, as for the negotiations with BP, the lysate patent is UCLA's, specific antigens. The methods for detecting the appropriate cancer cell protein from the lysate for a variety of cancers, including GBM (that patent was an outcome of the Regents agreement to write the IND and come up with GMP guidelines). The DC methods that are being used in combination with UCLA's patents (plural) are all NW Bio's. And within that SEC document I posted yesterday it is quiet clear (to everyone but one person) that NW Bio sought to protect their proprietary methods, and so it would not be in any protocol. If BP is going to test their CI with UCLA's lysate technology, it makes the most sense that it be done with DCVax platform manufacturing methods that have been tested (and possibly approved). The point is to get one of their CI through the regulatory pathway faster.